Successful therapy with rituximab in three patients with probable neurosarcoidosis

BACKGROUND: Neurosarcoidosis occurs in about 5–15% of patients with sarcoidosis. Therapy with corticosteroids is generally accepted as the first-line medication, followed by various immunomodulating and cytotoxic agents or combined therapy. However, some patients show an unsatisfactory outcome or ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zella, Samis, Kneiphof, Janina, Haghikia, Aiden, Gold, Ralf, Woitalla, Dirk, Thöne, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204624/
https://www.ncbi.nlm.nih.gov/pubmed/30386436
http://dx.doi.org/10.1177/1756286418805732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204624/
https://www.ncbi.nlm.nih.gov/pubmed/30386436
http://dx.doi.org/10.1177/1756286418805732

Ejemplares similares